Efficacy of fractional CO2 laser in the treatment of genitourinary syndrome of menopause in Latin‐American Population: First Peruvian experience

Objective This PUBA study aimed to assess the efficacy of fractional CO2 laser in the treatment of genitourinary syndrome of menopause (GSM). Methods GSM symptoms were assessed before, 1 month after the first session and 1 month after the third session of laser (3 sessions with a 30 days interval be...

Full description

Saved in:
Bibliographic Details
Published in:Lasers in surgery and medicine 2019-08, Vol.51 (6), p.509-515
Main Authors: Tovar‐Huamani, Juan, Mercado‐Olivares, Felipe, Grandez‐Urbina, Jose Antonio, Pichardo‐Rodriguez, Rafael, Tovar‐Huamani, Marco, García‐Perdomo, Herney
Format: Article
Language:English
Subjects:
Bladder
Burning
Carbon dioxide
Carbon dioxide lasers
dyspareunia
Frost
genitourinary syndrome of menopause
Itching
laser Gas
Lasers
Menopause
Pruritus
Quasi-experimental methods
quasi‐experimental study
Signs and symptoms
Vagina
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective This PUBA study aimed to assess the efficacy of fractional CO2 laser in the treatment of genitourinary syndrome of menopause (GSM). Methods GSM symptoms were assessed before, 1 month after the first session and 1 month after the third session of laser (3 sessions with a 30 days interval between them) in 60 women (median, interquartile range: 55, 49–69). Subjective (visual analog scale) and objective (Vaginal Health Index, VHIS; Vaginal Maturity Index/Frost Index; Spanish Overactive Bladder Questionnaire‐Short Form, USMEX Spanish OAB‐qSF and Female Sexual Function Index, FSFI) measures were used during the study period to assess CO2 fractionated laser treatment outcomes compared to baseline. Results Fractional CO2 laser treatment was effective to improve GSM symptoms (vaginal dryness, vaginal itching, vaginal burning, dyspaurenia, dysuria, urinary urgency; P 
ISSN:0196-8092
1096-9101
DOI:10.1002/lsm.23066